Countryfocus healthcare, regulatory and reimbursement landscape philippines

Page 1

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape Philippines Released On 27th June 2014 The industry analysis specialist, has released its latest report, CountryFocus: Healthcare, Regulatory and Reimbursement Landscape Philippines. The report is an essential source of information and analysis regarding the healthcare, regulatory and reimbursement landscape in the Philippines. It identifies key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure in the country. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. This resource has been produced using data and information from proprietary databases, secondary research, and in-house analysis by GlobalDatas team of industry experts. Buy this report OR Know more : http://www.jsbmarketresearch.com/healthcaremedical/r-CountryFocus-Healthcare-Regulatory-and-Reimbursement-LandscapePhilippines-114974 The population of the Philippines amounted to approximately 99.2 million in 2013, making it the 12th most populated country in the world. Population growth has primarily been due to a high birth rate and rising life expectancy. An increased elderly population is however a matter of concern for policy planners. The value of the pharmaceutical market in the country amounted to $4.3 billion in 2013, and it is expected to increase at a CAGR of 9.4% to reach approximately $8 billion in 2020. The positive trend in the healthcare market of the Philippines can be attributed primarily to the following factors: Generic substitution in both the public and private sectors, which has been a driver for the manufacture of generic drugs Increased expenditure on medicines by Local Government Units (LGUs) Government initiatives for the prevention and management of chronic diseases An improved and updated regulatory environment Scope This report provides information on the healthcare, regulatory, and reimbursement landscape in the Philippines, including the following: JSB Market Research Pvt. Ltd.

Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 / +91 - 998 729 5242 Published by- http:/www.jsbmarketresearch.com/


An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers Profiles and SWOT analyses for major players in the pharmaceutical market (United Laboratories, Pfizer, GlaxoSmithKline, Novartis, Merck) An insightful review of the reimbursement and regulatory landscape, including details of the healthcare reimbursement process, regulatory agencies, and approval processes for new drugs and medical devices Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure, and healthcare expenditure An overview of the opportunities for and challenges facing growth in the healthcare market Reasons To Buy This report will enhance your decision-making capability by allowing you to: Develop business strategies based on a sound understanding of the trends shaping and driving the healthcare market in the Philippines Generate revenue based upon knowledge of key trends, reimbursement and regulatory policies, pharmaceutical market segments, and the companies likely to impact the healthcare market in the future Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors Organize sales and marketing efforts by identifying the market categories and segments that present the greatest opportunities for consolidation, investment, and strategic partnership Identify, understand, and capitalize upon the opportunities and challenges in the Philippines healthcare market Table of Content: 1.1 List of Tables 1.2 List of Figures 2 Introduction 2.1 GlobalData Report Guidance 3 Overview of Pharmaceutical and Medical Device Market 3.1 Pharmaceutical Market 3.1.1 Market Overview JSB Market Research Pvt. Ltd.

Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 / +91 - 998 729 5242 Published by- http:/www.jsbmarketresearch.com/


3.1.2 Pharmaceutical Exports and Imports 3.1.3 Supply Channels 3.1.4 Market Segments 3.1.5 Overview of Major Disease Areas 3.1.6 Major Players 3.2 Medical Device Market 3.2.1 Market Overview 3.3 Market Drivers and Barriers 3.3.1 Drivers 3.3.2 Barriers 4 Market Access 4.1 Reimbursement and Payer Landscape 4.1.1 Overview of Healthcare system 4.1.2 Reimbursement Process 4.1.3 Overview of Insurance Providers 4.1.4 Patient Share in Healthcare Spending 4.1.5 Price Trends in the Healthcare Sector 4.1.6 Pricing Policies 4.2 Regulatory Landscape 4.2.1 Overview of Regulatory Agencies JSB Market Research Pvt. Ltd.

Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 / +91 - 998 729 5242 Published by- http:/www.jsbmarketresearch.com/


4.2.2 Market Authorization Procedure for Pharmaceutical Products 4.2.3 New Medical Device Approval Process 4.2.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing 4.2.5 Exports and Imports 4.2.6 Intellectual Property Rights 4.2.7 Clinical Trial Regulations 4.2.8 Pharmaceutical Advertising Regulations 4.2.9 Pharmacy Regulations 4.2.10 Labeling and Packaging Regulations 5 Country Analysis 5.1 Political Environment 5.1.1 Political Structure 5.1.2 Analysis of Current Political Environment 5.1.3 Healthcare Policy Initiatives 5.2 Economic Landscape 5.3 Economic Indicators 5.3.1 Gross Domestic Product 5.3.2 Gross National Income 5.3.3 Inflation 5.3.4 Currency Exchange Rate 5.3.5 Foreign Direct Investment JSB Market Research Pvt. Ltd.

Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 / +91 - 998 729 5242 Published by- http:/www.jsbmarketresearch.com/


5.3.6 Foreign Exchange Reserves 5.3.7 Trade Balance 5.3.8 Fiscal Deficit 5.3.9 General Government Gross Debt 5.3.10 External Debt 5.3.11 Major Industries 5.4 Demographics 5.4.1 Population 5.4.2 Education and Literacy 5.4.3 Employment 5.4.4 Disease Burden 5.5 Healthcare Infrastructure 5.5.1 Healthcare Facilities 5.5.2 Healthcare Parameters 5.5.3 Environmental Health 5.5.4 Healthcare Personnel 5.6 Healthcare Expenditure 5.6.1 Overview 5.6.2 Major Components of Healthcare Spending 5.6.3 Share of Public and Private Sector JSB Market Research Pvt. Ltd.

Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 / +91 - 998 729 5242 Published by- http:/www.jsbmarketresearch.com/


5.6.4 Spending in Pharmaceutical R&D 5.7 Trade Associations 5.7.1 Pharmaceutical and Healthcare Association of the Philippines 5.7.2 The Philippine Pharmaceutical Manufacturers Association 5.7.3 The Philippine Pharmacist Association 5.7.4 The Philippine Medical Association 5.8 Trade Fairs 6 Opportunities and Challenges 6.1 Opportunities 6.2 Challenges 7 Appendix 7.1 Abbreviations 7.2 Bibliography 7.3 Research Methodology 7.3.1 Coverage 7.3.2 Secondary Research 7.3.3 Forecasts 7.3.4 Expert Panel 7.4 Disclaimer List of Tables Table 1: Pharmaceutical Market, Philippines, Revenue ($bn), 20082013 JSB Market Research Pvt. Ltd.

Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 / +91 - 998 729 5242 Published by- http:/www.jsbmarketresearch.com/


Table 2: Pharmaceutical Market, Philippines, Revenue Forecast ($bn), 20142020 Table 3: Pharmaceutical Market, Philippines, Exports and Imports ($m), 20082013 Table 4: Pharmaceutical Market, Philippines, Price Distribution of Pharmaceuticals for Multinational Companies (%), 2008 Table 5: Pfizer, Global, Major Products, Revenue, 2013 Table 6: Pharmaceutical Market, Global, Late-Stage Pipeline, Pfizer, 2014 Table 7: GlaxoSmithKline, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2013 Table 8: Pharmaceutical Market, Global, Late-Stage Pipeline, GlaxoSmithKline, 2014 Table 9: Novartis, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2013 Table 10: Pharmaceutical Market, Global, Planned Filings, Novartis, 2014=2018 Table 11: Merck, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2013 Table 12: Pharmaceutical Market, Global, Late-Stage Pipeline, Merck, 2014 Table 13: Membership in PhilHealth, Philippines, Sector Share (%), 2013 Table 14: Benefit Payments from PhilHealth, Philippines, Sector Share (%), 2013 Table 15: Healthcare Spending, Philippines, Out-of-Pocket Expenditure (%), 20082013 Table 16: Price of Healthcare Products, Philippines Change in Average Price of Health Sector (%), 20082013 Table 17: Economic Indicators, Philippines, Gross Domestic Product per Capita ($), 20082013 Table 18: Economic Indicators, Philippines, Gross Domestic Product per Capita Forecast ($), 20142020 Table 19: Economic Indicators, Philippines, Gross Domestic Product Annual Growth (%), 20082013 JSB Market Research Pvt. Ltd.

Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 / +91 - 998 729 5242 Published by- http:/www.jsbmarketresearch.com/


Table 20: Economic Indicators, Philippines, Gross Domestic Product Annual Growth (%), 20142020 Table 21: Economic Indicators, Philippines, Gross National Income per Capita ($), 20082013 Table 22: Economic Indicators, Philippines, Average Consumer Price Index, 20082013 Table 23: Economic Indicators, Philippines, Average Consumer Price Annual Change (%), 20082013 Table 24: Economic Indicators, Philippines, Currency Exchange Rate (PHP/$), 20082013 Table 25: Economic Indicators, Philippines, Foreign Direct Investment ($bn), 20082013 Table 26: Economic Indicators, Philippines, Foreign Exchange Reserves ($bn), 20082013 Table 27: Economic Indicators, Philippines, Imports of Goods and Services ($bn), 20082013 Table 28: Economic Indicators, Philippines, Exports of Goods and Services ($bn), 20082013 Table 29: Economic Indicators, Philippines, Fiscal Deficit (% of GDP), 20082012 Table 30: Economic Indicators, Philippines, General Government Gross Debt (% of GDP), 20082013 Table 31: Economic Indicators, Philippines, External Debt ($bn), 20082013 Table 32: Economic Indicators, Philippines, Major Industries, Industrial Sector, Gross Value Added ($bn), 20122013 Table 33: Economic Indicators, Philippines, Major Industries, Service Sector, Gross Value Added ($bn), 20122013 Table 34: Demographics, Philippines, Population (million), 20082013 Table 35: Demographics, Philippines, Population Forecast (million), 20142020 Table 36: Demographics, Philippines, Population, Urban and Rural Population Share (%), 20082013 JSB Market Research Pvt. Ltd.

Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 / +91 - 998 729 5242 Published by- http:/www.jsbmarketresearch.com/


Table 37: Demographics, Philippines, Population, Urban and Rural Population Forecast Share (%), 20142020 Table 38: Demographics, Philippines, Population Distribution by Age Group (%), 20082013 Table 39: Demographics, Philippines, Population Distribution by Age Group Forecast (%), 20082013 Table 40: Demographics, Philippines, Births (per 1,000 Population), 20082013 Table 41: Demographics, Philippines, Mortality (per 1,000 Population), 20082013 Table 42: Demographics, Philippines, Major Causes of Mortality (000), 2010 Table 43: Demographics, Philippines, Infant Mortality (per 1,000 Live Births), 20082013 Table 44: Demographics, Philippines, Immunization Rate (%), 20082013 Table 45: Demographics, Philippines, Major Causes of Male Mortality (000), 2008 Table 46: Demographics, Philippines, Major Causes of Female Mortality (000), 2008 Table 47: Demographics, Philippines, Maternal Mortality (per 1,000 Live Births), 20082010 Table 48: Demographics, Philippines, Gender Ratio (M:F), 20082013 Table 49: Demographics, Philippines, Life Expectancy at Birth (Years), 20082013 Table 50: Demographics, Philippines, Life Expectancy at Birth (Years), 20142020 Table 51: Demographics, Philippines, Student Enrollment by Level of Education (%), 20082013 Table 52: Demographics, Philippines, Unemployment Rate (%), 20082013 Table 53: Demographics, Philippines, Major Diseases, Morbidity (000), 2010 Table 54: Demographics, Philippines, Major Diseases, DALYs (per 100,000 Population), 2009 Table 55: Healthcare Infrastructure, Philippines, Hospitals, 20082013 Table 56: Healthcare Infrastructure, Philippines, Barangay Health Stations, 20082013 JSB Market Research Pvt. Ltd.

Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 / +91 - 998 729 5242 Published by- http:/www.jsbmarketresearch.com/


Table 57: Healthcare Infrastructure, Philippines, Hospitals by Standard of Care, 2009 Table 58: Healthcare Infrastructure, Philippines, Diagnostic Equipment (per 100,000 Population), 20072009 Table 59: Healthcare Infrastructure, Philippines, Hospitals Beds (per 10,000 Population), 20082013 Table 60: Environmental Health, Philippines, CO2 Emissions (Million Tons), 20082013 Table 61: Environmental Health, Philippines, PM10 (gm/m), 20082013 Table 62: Healthcare Personnel, Philippines, Registered Healthcare Personnel, 20082013 Table 63: Healthcare Personnel, Philippines, Registered Nurses, 20082013 Table 64: Healthcare Expenditure, Philippines, Healthcare Expenditure (% of GDP), 20082013 Table 65: Healthcare Expenditure, Philippines, Share of Major Components (%), 2011 Table 66: Healthcare Expenditure, Philippines, Public-Private Share (%), 20082013 Table 67: Major Healthcare Trade Fairs, Philippines, 2014 List of Figures Figure 1: Pharmaceutical Market, Philippines, Revenue ($bn), 20082013 Figure 2: Pharmaceutical Market, Philippines, Revenue Forecast ($bn), 20142020 Figure 3: Pharmaceutical Market, Philippines, Exports and Imports ($m), 20082013 Figure 4: Pharmaceutical Distribution Channel, Philippines, Distribution Share (%), 2008 Figure 5: Pharmaceutical Market, Philippines, Price Distribution of Pharmaceuticals for Multinational Companies (%), 2008 Figure 6: Healthcare Market, Philippines, Drivers and Barriers, 2013 Figure 7: Healthcare System, Philippines, 2014 JSB Market Research Pvt. Ltd.

Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 / +91 - 998 729 5242 Published by- http:/www.jsbmarketresearch.com/


Figure 8: Drug Selection Procedure for Philippine National Drug Formulary, Philippines, 2014 Figure 9: Reimbursement Process, Philippines, 2014 Figure 10: PhilHealth Milestones, Philippines, 2010 Figure 11: Membership in PhilHealth, Philippines, Sector Share (%), 2013 Figure 12: Benefit Payments from PhilHealth, Philippines, Sector Share (%), 2013 Figure 13: Healthcare Spending, Philippines, Out-of-Pocket Expenditure (%), 20082013 Figure 14: Price of Healthcare Products, Philippines, Change in Average Price of Health Sector (%), 20082013 Figure 15: Healthcare System, Philippines, Food and Drug Administration Structure, 2014 Figure 16: Healthcare System, Philippines, Approval Process of New Drugs and Medical Devices, 2014 Figure 17: Healthcare System, Philippines, Approval Process of Generic Drugs, 2014 Figure 18: Healthcare System, Philippines, Bureau of Health Devices and Technology Structure, 2014 Figure 19: Healthcare System, Philippines, Licensing Process for Manufacture of Pharmaceuticals and Medical Devices, 2014 Figure 20: Healthcare System, Philippines, Patent Approval Process, 2014 Figure 21: Healthcare System, Philippines, Trademark Approval Process, 2014 Figure 22: Healthcare System, Philippines, Clinical Trial Approval Process, 2014 Figure 23: Healthcare System, Philippines, Procedure for Opening a Retail Pharmacy, 2014 Figure 24: Healthcare Policy Initiatives, Philippines, Major Healthcare Reforms, 19992010 Figure 25: Economic Indicators, Philippines, Gross Domestic Product per Capita ($), 20082013 JSB Market Research Pvt. Ltd.

Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 / +91 - 998 729 5242 Published by- http:/www.jsbmarketresearch.com/


Figure 26: Economic Indicators, Philippines, Gross Domestic Product per Capita Forecast ($), 20142020 Figure 27: Economic Indicators, Philippines, Gross Domestic Product Annual Growth (%), 20082013 Figure 28: Economic Indicators, Philippines, Gross Domestic Product Annual Growth Forecast (%), 20142020 Figure 29: Economic Indicators, Philippines, Gross National Income per Capita ($), 20082013 Figure 30: Economic Indicators, Philippines, Average Consumer Price Index, 20082013 Figure 31: Economic Indicators, Philippines, Average Consumer Price Annual Change (%), 20082013 Figure 32: Economic Indicators, Philippines, Currency Exchange Rate (PHP/$), 20082013 Figure 33: Economic Indicators, Philippines, Foreign Direct Investment ($bn), 20082013 Figure 34: Economic Indicators, Philippines, Foreign Exchange Reserves ($bn), 20082013 Figure 35: Economic Indicators, Philippines, Imports of Goods and Services ($bn), 20082013 Figure 36: Economic Indicators, Philippines, Exports of Goods and Services ($bn), 20082013 Figure 37: Economic Indicators, Philippines, Fiscal Deficit (% of GDP), 20082012 Figure 38: Economic Indicators, Philippines, General Government Gross Debt (% of GDP), 20082013 Figure 39: Economic Indicators, Philippines, External Debt ($bn), 20082013 Figure 40: Economic Indicators, Philippines, Major Industries, Industrial Sector, Gross Value Added ($bn), 20122013 Figure 41: Economic Indicators, Philippines, Major Industries, Service Sector, Gross Value Added ($bn), 20122013 Figure 42: Demographics, Philippines, Population (million), 20082013 Figure 43: Demographics, Philippines, Population Forecast (million), 20142020 Figure 44: Demographics, Philippines, Population, Urban and Rural Population Share (%), 20082013 Figure 45: Demographics, Philippines, Population, Urban and Rural Population Share Forecast (%), 20142020 Figure 46: Demographics, Philippines, Population Distribution by Age Group (%), 20082013 Figure 47: Demographics, Philippines, Population Distribution by Age Group Forecast (%), 20142020 Figure 48: Demographics, Philippines, Births (per 1,000 Population), 20082013 Figure 49: Demographics, Philippines, Mortality (per 1,000 Population), 20082013 Figure 50: Demographics, Philippines, Major Causes of Mortality (000), 2010 JSB Market Research Pvt. Ltd.

Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 / +91 - 998 729 5242 Published by- http:/www.jsbmarketresearch.com/


Figure 51: Demographics, Philippines, Infant Mortality (per 1,000 Live Births), 20082013 Figure 52: Demographics, Philippines, Immunization Rate (%), 20082013 Figure 53: Demographics, Philippines, Major Causes of Male Mortality (000), 2008 Figure 54: Demographics, Philippines, Major Causes of Female Mortality (000), 2008 Figure 55: Demographics, Philippines, Maternal Mortality (per 1,000 Live Births), 20082010 Figure 56: Demographics, Philippines, Gender Ratio (M:F), 20082013 Figure 57: Demographics, Philippines, Life Expectancy at Birth (Years), 20082013 Figure 58: Demographics, Philippines, Life Expectancy at Birth (Years), 20142020 Figure 59: Demographics, Philippines, Student Enrollment by Level of Education (%), 20082013 Figure 60: Demographics, Philippines, Unemployment Rate (%), 20082013 Figure 61: Demographics, Philippines, Major Diseases, Morbidity (000), 2010 Figure 62: Demographics, Philippines, Major Diseases, DALYs (per 100,000 Population), 2009 Figure 63: Healthcare Infrastructure, Philippines, Hospitals, 20082013 Figure 64: Healthcare Infrastructure, Philippines, Barangay Health Stations, 20082013 Figure 65: Healthcare Infrastructure, Philippines, Hospitals by Standard of Care, 2009 Figure 66: Healthcare Infrastructure, Philippines, Diagnostic Equipment (per 100,000 Population), 20072009 Figure 67: Healthcare Infrastructure, Philippines, Hospitals Beds (per 10,000 Population), 20082013 Figure 68: Environmental Health, Philippines, CO2 Emissions (Million Tons), 20082013 Figure 69: Environmental Health, Philippines, PM10 (gm/m), 20082013 Figure 70: Healthcare Personnel, Philippines, Registered Healthcare Personnel, 20082013 Figure 71: Healthcare Personnel, Philippines, Registered Nurses, 20082013 Figure 72: Healthcare Expenditure, Philippines, Healthcare Expenditure (% of GDP), 20082013 Figure 73: Healthcare Expenditure, Philippines, Share of Major Components (%), 2011 Figure 74: Healthcare Expenditure, Philippines, Public-Private Share (%), 20082013 Related reports: •

Nasopharyngitis (Common Cold) - Pipeline Review, H1 2014

Skin Infections - Pipeline Review, H1 2014

Restenosis - Pipeline Review, H1 2014

Figure 75: Healthcare Market, Philippines, Opportunities and Challenges, 2013

JSB Market Research Pvt. Ltd.

Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 / +91 - 998 729 5242 Published by- http:/www.jsbmarketresearch.com/


About JSB Market Research:JSB market research is a leading player in the market of research report distribution. It is one-stop-shop for all information related to market research for any sector of the industry. Along with providing in-depth analysis though reports, JSB market research also provides regular updates of the market though newsletters. Our reports are a wellresearched work of market researchers with an extensive knowledge and a good level of market experience. To know more on “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape Philippines� http://www.jsbmarketresearch.com/healthcare-medical/r-CountryFocus-HealthcareRegulatory-and-Reimbursement-Landscape-Philippines-114974

JSB Market Research Pvt. Ltd.

Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 / +91 - 998 729 5242 Published by- http:/www.jsbmarketresearch.com/


Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.